Ambarish

Ambarish is an equity Partner at the Mumbai office of JSA and focuses on private and public mergers and acquisitions, and private equity investments.

Ambarish has advised on several multi-billion dollars transactions across sectors, including tender offers, and is sought for complicated listed company advisories. Ambarish also advises board of directors and senior management on corporate governance and high-risk matters.

In 2014, Ambarish advised the Government of India in setting up a regulatory framework for auction of coal mines; and has also assisted in drafting of several other regulations for the Government of India.*

In 2016, Ambarish worked at Mitsui & Co., Ltd at Tokyo, as a secondee for one year, where he was with the Asia Pacific Legal Department. Over the years, Ambarish has worked with several Japanese companies in their investment and management of portfolio in India.

Ambarish regularly publishes and speaks on matters related to foreign Investment and M&A.

 

Awards and Recognition

  • Top 10 M&A Lawyers in India league table by MergerLinks, 2022
  • Rising Stars by Asian Legal Business 2022
  • 40 Under 40 Rising Star by Legal Era, 2019

 

Memberships

  • Bar Council of Delhi
  • Ineternational Bar Association
  • Inter-Pacific Bar Association

 

Education

National Law University, Jodhpur (2008, Honours)

 

Languages

  • English
  • Hindi

Some of the key assignments for Ambarish include, advising:

  • TPG in the proposed merger of its investee company, Quality Care India Limited with Aster DM Healthcare Limited, at a combined valuation of over USD 5 billion.
  • Suven Pharmaceuticals in its over USD 3 billion merger of Cohance Livesciences with Suven (ongoing).
  • Advent in its over USD 1 billion control acquisition of Suven Pharmaceuticals Limitedthrough a share purchase and mandatory open offer.*
  • Mitsui and/or its affiliates in various investments in India.
  • TPG Rise Climatein its up to USD 1 billion investment in the electric vehicles business of Tata Motors. *
  • Biocon Biologics Limitedin its USD 3.3 billion (cash and stock) agreement to acquire global biosimilars business of Viatris Inc. *
  • PharmEasy, an Indian unicorn, in its ~INR 6334 Crores acquisition of Thyrocare Technologies Limited, a listed company, and related mandatory open offer. *
  • ACRE, an asset reconstruction company, in one of a kind financial restructuring of Jayaswal Neco Industries Ltd, a listed company, including equity issuance, while avoiding insolvency and mandatory open offer. *
  • TPGin its investment in Reliance Retail Ventures Limited. *
  • Asia Healthcare Holdings Pte. Ltd. in its fund raise from GIC. *
  • The Rise Climate Fund and Evercare in their successful approx. USD 1 billion exit from the Care Hospital Group*
  • TPGin its investment in Jio Platforms Limited. *
  • National Investment and Infrastructure Fundin obtaining an approximately USD 800 million funding commitment from the President of India. *
  • Altico Capital India Limiteda stressed debt-listed systematically important non-banking financial company in its financial resolution and eventual sale. *
  • Life Insurance Corporation of Indiain its USD 4.4 billion acquisition of majority shareholding in IDBI Bank Limitedthrough preferential issue and an open offer. *
  • Rise Fund SF Pte Ltd.in its investment in Fourth Partner Energy Private Limited, a distributed solar power company. *
  • Oil and Natural Gas Corporation Limitedin over USD 5 billion acquisition of 51% shareholding in Hindustan Petroleum Corporation Limited. *
  • Sumitomo Corporationin its joint-venture with Mahindra Agri Solutions Ltd. for crop care business. *
  • Ricoh Company Ltdwith respect to an alleged accounting fraud at its Indian subsidiary. *
  • Khazanah Nasional Berhad, the sovereign wealth fund of Malaysia in its investment in TransUnion CIBIL Limited, the major credit rating agency in India. *
  • TPG in its investment and partial exit from Solara Active Pharma, a public listed company. *
  • India Resurgence Fund(a Bain Capital and Piramal Enterprises partnership) and Dalmia Cement (Bharat) Limited, in over USD 1 billion uncompleted acquisition of Binani Cement Limited, contested up to the Supreme Court of India. *

 

* Matter handled prior to joining JSA.

Disclaimer & Confirmation


As per the rules of the Bar Council of India, we are not permitted to solicit work and advertise. By clicking on the “I AGREE” button below, you acknowledge the following:

If you have any legal issues, you, in all cases, must seek independent legal advice.

We use cookies to enhance your experience. By continuing to visit this website you agree to our use of cookies.